NCT05755945Active, not recruiting
A Study of Wearable Devices to Predict Migraines
A Prospective Feasibility Study Evaluating the Use of Wearable Devices to Predict and Track Clinical Outcomes in Chronic Migraine
Source: ClinicalTrials.gov · Last updated 11 Aug 2026
Brief summary (registry, in English)
The purpose of this research is to determine if data from smart devices, including heart rate and movement during sleep and wake times, will be able to track headaches and predict recurrence and exacerbations (make worse). This use of this information may in the future allow patients earlier and more effective treatments if these devices can help predict when the headaches may occur.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 23 Feb 2023
- Start date
- 24 Feb 2023
- Primary completion date
- Jun 2027
- Lead sponsor
- Mayo Clinic
- Diseases
- Migraine
- NCT number
- NCT05755945
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 24 Feb 2023 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Medication overuse headache as defined by the International Headache Society's International Classification of Headache Disorders (3rd edition).
- Daily opioid use for \> 3 months (e.g., hydrocodone, oxycodone, fentanyl patch) or other daily analgesic use for chronic pain disorders (e.g., NSAIDS or acetaminophen).
Other
- Chronic daily headache with no periods of headache freedom.
- ≥ 15 average number of headaches days per month during peak efficacy of preventative treatment.
- Inability or unwillingness of individual or legal guardian/representative to give written informed consent.
Who the study is looking for
- Age 18 years and older (no upper age limit defined)
- History of chronic migraine as defined by the International Headache Society's International Classification of Headache Disorders (3rd edition).
- Response to current preventative therapy with ≥ 50% improvement in the frequency of headache days when compared to baseline
- 4 to 14 average number of total headache days per month during peak efficacy of preventative therapy
- Ability to understand study procedures and to comply with them for the entire length of the study and use study devices as outlined in protocol.
- Patient agrees to maintain a daily electronic headache diary.
- Proficient in the use of electronic devices including Apple HomeKit and Apple Watch. - Subjects owns an iPhone with iOS 16 or later operating system installed on iPhone. Apple watch series 8 with watch OS6 or later will be provided by the study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic Minnesota Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.